Department of Women's Health, Dell Medical School, University of Texas at Austin, Austin, Texas.
Am J Perinatol. 2024 Nov;41(15):2033-2039. doi: 10.1055/a-2310-9817. Epub 2024 Apr 22.
Following the release of A Randomized Trial of Induction versus Expectant Management (ARRIVE) trial, the induction of labor at 39 weeks has increased in the United States. The risk of uterine rupture and optimal timing of elective induction in those patients with a prior cesarean delivery is not well-described, and they were not included in the original trial. We aimed to determine the risk of uterine rupture in those patients undergoing elective induction of labor with prior cesarean delivery.
This was a retrospective cohort of participants with prior cesarean delivery from 1996 to 2000. Participants were included if they had two or more prior cesareans. Participants were excluded if they had a history of an unknown prior incision, a classical incision, gestational age <39 weeks, any diabetes, chronic hypertension, twin gestation, collagen or vascular disease, or HIV. Those undergoing expectant management were compared with those undergoing elective induction with no medical or obstetrical indications for delivery. Analysis was performed at three gestational age groups: 39 weeks, 40 weeks, and 41 weeks. The primary outcomes were uterine rupture, rates of successful vaginal delivery, and a composite major morbidity risk. Multivariable logistic regression was performed.
At 39 weeks, 618 (10.3%) elective inductions were compared with 5,365 (89.7%) undergoing expectant management; uterine rupture occurred more frequently (13 patients [2.1%] vs. 49 patients [0.9%]; adjusted odds ratio [aOR], 2.5; 95% confidence interval, 1.3-4.6) with fewer successful vaginal birth after cesarean [VBAC; 66.8 vs. 75%; aOR, 0.6; 95% confidence interval, 0.5-0.7]. The risk of uterine rupture was similar between groups at 40 weeks (5 patients [0.8%] vs. 21 patients [1.2%]; = 0.387) and 41 weeks (7 patients [1.4%] vs. 2 patients (0.8%); = 0.448).
Patients undergoing elective induction of labor with a prior cesarean scar had an increased risk of uterine rupture when compared with expectant management at 39 weeks, with fewer successful VBAC.
· TOLAC elective induction at 39 weeks has an increased risk of uterine rupture.. · TOLAC elective induction at 39 weeks has a less successful chance of vaginal delivery.. · Awaiting spontaneous labor in this cohort does not increase the risk of uterine rupture..
在随机诱导分娩与期待管理试验(ARRIVE)公布后,美国的 39 周引产有所增加。对于有剖宫产史的患者,子宫破裂的风险以及选择性引产的最佳时机尚不清楚,且这些患者并未纳入原始试验。我们旨在确定有剖宫产史的患者选择性引产的子宫破裂风险。
这是一项对 1996 年至 2000 年有剖宫产史的参与者的回顾性队列研究。如果参与者有两次或两次以上剖宫产,则将其纳入研究。如果参与者有未知的既往切口史、经典切口史、妊娠龄<39 周、任何糖尿病、慢性高血压、双胎妊娠、胶原病或血管疾病或 HIV,则将其排除在外。将期待管理与无分娩医学或产科指征的选择性引产进行比较。分析在三个妊娠龄组进行:39 周、40 周和 41 周。主要结局为子宫破裂、阴道分娩成功率和复合主要不良发病率。进行多变量逻辑回归分析。
在 39 周时,比较了 618 例(10.3%)选择性引产与 5365 例(89.7%)期待管理;子宫破裂更常见(13 例[2.1%]与 49 例[0.9%];调整后的优势比[aOR],2.5;95%置信区间,1.3-4.6),且剖宫产阴道分娩后成功率较低[66.8%与 75%;aOR,0.6;95%置信区间,0.5-0.7]。在 40 周(5 例[0.8%]与 21 例[1.2%];=0.387)和 41 周(7 例[1.4%]与 2 例[0.8%];=0.448)时,两组间的子宫破裂风险相似。
与期待管理相比,有剖宫产史的患者选择性引产在 39 周时发生子宫破裂的风险增加,且剖宫产阴道分娩成功率较低。
· TOLAC 选择性引产在 39 周时发生子宫破裂的风险增加。
· TOLAC 选择性引产在 39 周时阴道分娩成功率降低。
· 在本队列中等待自然分娩不会增加子宫破裂的风险。